These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 30087892)
1. Technoeconomic Modeling of Plant-Based Griffithsin Manufacturing. Alam A; Jiang L; Kittleson GA; Steadman KD; Nandi S; Fuqua JL; Palmer KE; Tusé D; McDonald KA Front Bioeng Biotechnol; 2018; 6():102. PubMed ID: 30087892 [TBL] [Abstract][Full Text] [Related]
2. Improving the large scale purification of the HIV microbicide, griffithsin. Fuqua JL; Wanga V; Palmer KE BMC Biotechnol; 2015 Feb; 15(1):12. PubMed ID: 25887919 [TBL] [Abstract][Full Text] [Related]
3. In Preparation for Outdoor Pharming: Griffithsin Can Be Expressed in Eapen P; Cates J; Mundell R; Palmer KE; Fuqua JL Front Bioeng Biotechnol; 2020; 8():199. PubMed ID: 32258012 [TBL] [Abstract][Full Text] [Related]
4. Low-Cost, Large-Scale Production of the Anti-viral Lectin Griffithsin. Decker JS; Menacho-Melgar R; Lynch MD Front Bioeng Biotechnol; 2020; 8():1020. PubMed ID: 32974328 [TBL] [Abstract][Full Text] [Related]
5. Technoeconomic Modeling and Simulation for Plant-Based Manufacturing of Recombinant Proteins. McNulty MJ; Nandi S; McDonald KA Methods Mol Biol; 2022; 2480():159-189. PubMed ID: 35616864 [TBL] [Abstract][Full Text] [Related]
6. Bulk production of the antiviral lectin griffithsin. Fuqua JL; Hamorsky K; Khalsa G; Matoba N; Palmer KE Plant Biotechnol J; 2015 Oct; 13(8):1160-8. PubMed ID: 26176205 [TBL] [Abstract][Full Text] [Related]
7. Manufacturing economics of plant-made biologics: case studies in therapeutic and industrial enzymes. Tusé D; Tu T; McDonald KA Biomed Res Int; 2014; 2014():256135. PubMed ID: 24977145 [TBL] [Abstract][Full Text] [Related]
8. High-level expression of the HIV entry inhibitor griffithsin from the plastid genome and retention of biological activity in dried tobacco leaves. Hoelscher M; Tiller N; Teh AY; Wu GZ; Ma JK; Bock R Plant Mol Biol; 2018 Jul; 97(4-5):357-370. PubMed ID: 29948657 [TBL] [Abstract][Full Text] [Related]
9. Rice endosperm is cost-effective for the production of recombinant griffithsin with potent activity against HIV. Vamvaka E; Arcalis E; Ramessar K; Evans A; O'Keefe BR; Shattock RJ; Medina V; Stöger E; Christou P; Capell T Plant Biotechnol J; 2016 Jun; 14(6):1427-37. PubMed ID: 26800650 [TBL] [Abstract][Full Text] [Related]
10. An approach to rapid distributed manufacturing of broad spectrum anti-viral griffithsin using cell-free systems to mitigate pandemics. Borhani SG; Levine MZ; Krumpe LH; Wilson J; Henrich CJ; O'Keefe BR; Lo DC; Sittampalam GS; Godfrey AG; Lunsford RD; Mangalampalli V; Tao D; LeClair CA; Thole AP; Frey D; Swartz J; Rao G N Biotechnol; 2023 Sep; 76():13-22. PubMed ID: 37054948 [TBL] [Abstract][Full Text] [Related]
11. Efficient single tobamoviral vector-based bioproduction of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 in Nicotiana benthamiana plants and utility of VRC01 in combination microbicides. Hamorsky KT; Grooms-Williams TW; Husk AS; Bennett LJ; Palmer KE; Matoba N Antimicrob Agents Chemother; 2013 May; 57(5):2076-86. PubMed ID: 23403432 [TBL] [Abstract][Full Text] [Related]
12. Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component. O'Keefe BR; Vojdani F; Buffa V; Shattock RJ; Montefiori DC; Bakke J; Mirsalis J; d'Andrea AL; Hume SD; Bratcher B; Saucedo CJ; McMahon JB; Pogue GP; Palmer KE Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6099-104. PubMed ID: 19332801 [TBL] [Abstract][Full Text] [Related]
13. An approach to rapid distributed manufacturing of broad spectrum anti-viral griffithsin using cell-free systems to mitigate pandemics. Borhani SG; Levine MZ; Krumpe LH; Wilson J; Henrich CJ; Oâ Keefe BR; Lo D; Sittampalam GS; Godfrey AG; Lunsford RD; Mangalampalli V; Tao D; LeClair CA; Thole A; Frey D; Swartz J; Rao G bioRxiv; 2022 Dec; ():. PubMed ID: 36597541 [TBL] [Abstract][Full Text] [Related]
14. Griffithsin: An Antiviral Lectin with Outstanding Therapeutic Potential. Lusvarghi S; Bewley CA Viruses; 2016 Oct; 8(10):. PubMed ID: 27783038 [TBL] [Abstract][Full Text] [Related]
15. Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virus. Moulaei T; Alexandre KB; Shenoy SR; Meyerson JR; Krumpe LR; Constantine B; Wilson J; Buckheit RW; McMahon JB; Subramaniam S; Wlodawer A; O'Keefe BR Retrovirology; 2015 Jan; 12():6. PubMed ID: 25613831 [TBL] [Abstract][Full Text] [Related]
16. Integrated autolysis, DNA hydrolysis and precipitation enables an improved bioprocess for Q-Griffithsin, a broad-spectrum antiviral and clinical-stage anti-COVID-19 candidate. Decker JS; Menacho-Melgar R; Lynch MD Biochem Eng J; 2022 Apr; 181():108403. PubMed ID: 35308834 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor. Cao N; Cai Y; Huang X; Jiang H; Huang Z; Xing L; Lu L; Jiang S; Xu W mBio; 2024 May; 15(5):e0074124. PubMed ID: 38587427 [TBL] [Abstract][Full Text] [Related]
18. Antiviral lectin Q-Griffithsin suppresses fungal infection in murine models of vaginal candidiasis. Nabeta HW; Lasnik AB; Fuqua JL; Wang L; Rohan LC; Palmer KE Front Cell Infect Microbiol; 2022; 12():976033. PubMed ID: 36329822 [TBL] [Abstract][Full Text] [Related]